Search

Bruce Xuefeng Ling

from Palo Alto, CA
Age ~56
Get Report
Also known as:
Bruce X Ling, Xuefeng Feng Ling, Xuo Feng Ling, Xuefeng F Ling, Xuefeng W Ling, Xuo F Ling, G Ling, Feng Ling Xuefeng, Feng Ling Xue, Feng Ling Xuo
Phone and address:
1400 Waverley St, Palo Alto, CA 94301
Related to:
Wei C Chen, 47Kristy Chen, 57Stephen HeLin C Lin, 62Mei L Chen, 48
Connected to:
Alfred S Ling, 96Angeline M Ling, 99Annette M Ling, 47Anson Ling, 41Aung Ling, 44Bee W Ling, 61Brandi S Ling, 30Cameron R Ling, 27Che Ling, 34Christine Ling, 45

Bruce Ling Phones & Addresses

  • 1400 Waverley St, Palo Alto, CA 94301
  • East Palo Alto, CA
  • Redwood City, CA
  • Menlo Park, CA
  • San Jose, CA
  • Los Angeles, CA
  • Fremont, CA
  • Santa Clara, CA
  • Novato, CA
  • Iowa City, IA

Education

Degree: High school graduate or higher

Resumes

Resumes

Bruce Ling Photo 1

Bruce Ling

View page
Location:
1400 Waverley St, Palo Alto, CA 94301
Industry:
Biotechnology
Interests:
Cooking
Exercise
Investing
Electronics
Home Improvement
Reading
Crafts
Gourmet Cooking
Home Decoration
Languages:
English
Bruce Ling Photo 2

Principal Investigator

View page
Location:
Palo Alto, CA
Industry:
Research
Work:
Stanford University
Principal Investigator
Stanford University Jan 2006 - Dec 2010
Senior Scientist
Amgen May 2004 - Nov 2005
Director, R and D Informatics
Tularik Mar 2001 - May 2004
Research Director
Double Twist 1999 - 2001
Associate Director, Research
Education:
University of California, Los Angeles
Fudan University
Stanford University
Skills:
Molecular Biology
Biotechnology
Drug Discovery
Computational Biology
Protein Chemistry
Genomics
Bioinformatics
Cell Biology
R&D
Biochemistry
Lifesciences
Life Sciences
Statistics
Drug Development
Translational Medicine
Cell Culture
Immunology
Cell
Genetics
Medicinal Chemistry
Clinical Trials
Cancer
Biomarkers
Medical Devices
Proteomics
Bruce Ling Photo 3

Bruce Ling

View page
Bruce Ling Photo 4

Bruce Ling

View page
Bruce Ling Photo 5

Bruce Ling

View page
Location:
United States

Business Records

Name / Title
Company / Classification
Phones & Addresses
Bruce X. Ling
Healthcare Business Intelligence Solutions LLC
Software & Services for Healthcare Organ · Software and Services for Hospitals Phys
530 Lytton Ave, Palo Alto, CA 94301
1 Maritime Plz, San Francisco, CA 94111

Publications

Us Patents

Methods For Diagnosis Of Systemic Juvenile Idiopathic Arthritis

View page
US Patent:
20130052665, Feb 28, 2013
Filed:
Aug 20, 2012
Appl. No.:
13/589727
Inventors:
Bruce Xuefeng Ling - Palo Alto CA, US
Elizabeth D. Mellins - Stanford CA, US
International Classification:
G01N 33/566
G01N 21/64
US Classification:
435 792, 436501
Abstract:
Methods for diagnosis of systemic juvenile idiopathic arthritis (SJIA) are disclosed. In particular, the invention relates to the use of biomarkers for diagnosis of SJIA, which can be used to distinguish SJIA from other inflammatory diseases, including infectious illness, acute febrile illness, Kawasaki disease, and similar juvenile idiopathic arthritis (JIA) disease subtypes, and to predict inflammatory flares in SJIA patients in advance of clinical symptoms.

Methods For Diagnosis Of Kawasaki Disease

View page
US Patent:
20130316921, Nov 28, 2013
Filed:
Jun 5, 2013
Appl. No.:
13/910817
Inventors:
John C. Whitin - Palo Alto CA, US
Bruce Xuefeng Ling - Palo Alto CA, US
James Schilling - San Mateo CA, US
Assignee:
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA - Oakland CA
THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY - Palo Alto CA
International Classification:
C12Q 1/68
G01N 33/68
US Classification:
506 7, 435 792, 436501, 435 612, 435 611
Abstract:
Methods for diagnosis of Kawasaki disease (KD) are disclosed. In particular, the invention relates to the use of biomarkers for aiding diagnosis, prognosis, and treatment of KD, and more specifically to biomarkers that can be used to distinguish KD from other inflammatory diseases, including infectious illness and acute febrile illness.

Biomarkers For The Diagnosis Of Kidney Graft Rejection

View page
US Patent:
20120283123, Nov 8, 2012
Filed:
Nov 24, 2010
Appl. No.:
13/508013
Inventors:
Minnie M. Sarwal - Portola Valley CA, US
Bruce Xuefeng Ling - Palo alto CA, US
Tara Sigdel - Palo Alto CA, US
James Schilling - San Mateo CA, US
International Classification:
G01N 27/72
C40B 30/04
C40B 40/06
C12Q 1/68
US Classification:
506 9, 435 612, 436 86, 506 16
Abstract:
Methods are provided for determining a transplant category of a subject having a kidney graft. In practicing one aspect of the subject methods, the peptide signature of a non-invasive sample derived from the transplant subject (e.g., a urine sample) is used to determine the subject's transplant category (e.g., acute allograft rejection (AR), stable allograft (STA), BK virus nephropathy (BK), and the like). In other embodiments, a gene expression signature from a biopsy sample from the subject (e.g., mRNA level) is used to determine the subject's transplant category. In certain embodiments both a peptide signature and a gene expression signature are used. Also provided are compositions, systems, kits and computer program products that find use in practicing the subject methods.

Novel Diagnostic Algorithm For Acute Kidney Injury In Hospitalized Children

View page
US Patent:
20160317075, Nov 3, 2016
Filed:
Sep 12, 2014
Appl. No.:
14/485575
Inventors:
- Palo Alto CA, US
Bruce Xuefeng Ling - Palo Alto CA, US
Scott Sutherland - Palo Alto CA, US
International Classification:
A61B 5/20
G06F 19/00
A61B 5/00
Abstract:
We have developed a novel AKI diagnostic algorithm upon KID 2009 database. The KID is multi-featured and the AKI and non-AKI groups are highly imbalanced, making it challenging to describe them via simple linear statistics. Thus, to identify features effectively, our AKI association studies employed statistical learning strategies; a predictive model was created to accurately determine which KID data elements were highly associated with an AKI diagnosis. We employed prediction analysis of microarrays (PAM), which is commonly applied to high-feature datasets such as DNA microarrays; PAM determines which data elements, or features, best contribute to the predictive model or characterize individual classes/cohorts, Clinical Classification Software codes (286 diagnosis, 231 procedural) were used to bin ICD-9-CM codes (n=6,722) and analyzed by PAM. PAM identified relevant AKI predictors and eliminated irrelevant data elements, which constitute noise.

Biomarkers For Ovarian Cancer

View page
US Patent:
20160291024, Oct 6, 2016
Filed:
Sep 17, 2014
Appl. No.:
14/914245
Inventors:
- Stanford CA, US
Linda Anne Szabo - Belmont CA, US
Purvesh Khatri - Menlo Park CA, US
Bruce Xuefeng Ling - Palo Alto CA, US
Assignee:
THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY - Stanford CA
International Classification:
G01N 33/574
Abstract:
Biomarkers and biomarker panels are provided for making ovarian cancer assessments, for example, diagnosing an ovarian cancer, predicting responsiveness of an ovarian cancer to an ovarian cancer therapy, and monitoring an ovarian cancer. A patient may further be treated in accordance with the classification. Also provided are methods, reagents, devices and kits for the use of these biomarkers in making ovarian cancer assessments.

Methods For Diagnosis Of Kawasaki Disease

View page
US Patent:
20150377905, Dec 31, 2015
Filed:
Jun 24, 2015
Appl. No.:
14/749604
Inventors:
- Palo Alto CA, US
- Oakland CA, US
Jun Ji - Qingdao, CN
Bo Jin - Mountain View CA, US
Bruce Xuefeng Ling - Palo Alto CA, US
Zhou Tan - Stanford CA, US
Adriana Tremoulet - San Diego CA, US
International Classification:
G01N 33/68
Abstract:
Methods for diagnosis of Kawasaki disease (KD) are disclosed. In particular, the invention relates to the use of biomarkers for aiding diagnosis, prognosis, and treatment of KD, and to a panel of biomarkers that can be used to distinguish KD from febrile illness.

Methods And Compositions For Providing A Preeclampsia Assessment

View page
US Patent:
20150099655, Apr 9, 2015
Filed:
May 7, 2013
Appl. No.:
14/396721
Inventors:
- Palo Alto CA, US
Bruce Xuefeng Ling - Palo Alto CA, US
Linda Liu Miller - Philadelphia PA, US
Alexander A. Morgan - Palo Alto CA, US
Gongxing Chen - Stanford CA, US
Jun Ji - Palo Alto CA, US
Ting Yang - San Jose CA, US
International Classification:
G01N 33/68
G06F 19/00
G06F 19/20
US Classification:
506 9, 506 18, 506 39, 702 19
Abstract:
Preeclampsia markers, preeclampsia marker panels, and methods for obtaining a preeclampsia marker level representation for a sample are provided. These compositions and methods find use in a number of applications, including, for example, diagnosing preeclampsia, prognosing a preeclampsia, monitoring a subject with preeclampsia, and determining a treatment for preeclampsia. In addition, systems, devices and kits thereof that find use in practicing the subject methods are provided.
Control profile
Bruce Xuefeng Ling from Palo Alto, CA, age ~56 Get Report